Altshuler Shaham LTD Madrigal Pharmaceuticals, Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $174,376 - $317,896	-3,120 Reduced 59.37%	2,135 $209,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $264,144 - $320,880	-2,400 Reduced 31.35%	5,255 $584,000
Q1 2020 May 12, 2020	BUY	$66.76 - $93.49 $13,552 - $18,978	203 Added 2.72%	7,655 $511,000
Q3 2019 Nov 12, 2019	BUY	$84.4 - $106.53 $7,005 - $8,841	83 Added 1.13%	7,452 $648,000
Q2 2019 Aug 06, 2019	BUY	$91.13 - $142.5 $32,442 - $50,730	356 Added 5.08%	7,369 $772,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $236,555 - $328,818	2,286 Added 48.36%	7,013 $878,000
Q4 2018 Feb 11, 2019	SELL	$94.77 - $215.54 $1,232 - $2,802	-13 Reduced 0.27%	4,727 $533,000
Q3 2018 Nov 13, 2018	BUY	$207.3 - $300.31 $982,602 - $1.42 Million	4,740 New	4,740 $1.02 Million

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.